1Sahoo, S, Manoj, K. Antipsychotic‐induced urinary dysfunction: anticholinergic effect or otherwise? BMJ Case Rep 2009. DOI: bcr02.2009.1547.
2Ambrosini, PJ. A pharmacological paradigm for urinary incontinence and enuresis. J Clin Psychopharmacol 1984;4:247–253.
3Ambrosini, PJ, Nurnberg, HG. Urinary incontinence and neuroleptics. Am J Psychiatry 1982;139:539.
4Sagar, R, Varghese, ST, Balhara, YP. Olanzapine‐induced double incontinence. Indian J Med Sci 2005;59:163–164.
5Benazzi, F. Urinary retention with fluoxetine–haloperidol combination in a young patient. Can J Psychiatry 1996;41:606–607.
6Kiruluta, HG, Andrews, K. Urinary incontinence secondary to drugs. Urology 1983;22:88–90.
7Myung‐Ji, L, Chul‐Eung, K. Use of aripiprazole in clozapine induced enuresis: report of two cases. J Korean Med Sci 2010;25:333–335.
8Herguner, S, Mukaddes, NM. Risperidone‐induced double incontinence. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1085–1086.
9Fraser, MO, Chancellor, MB. Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence. BJU Int 2003;91:743–748.
10Deeks, ED. Risperidone long‐acting injection in bipolar I disorder. Drugs 2010;70:1001.012.
11Vera, PL, Miranda‐Sousa, A, Nadelhaft, I. Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats. BMC Pharmacol 2001;1:4.
12Kirshner, A, Davis, RR. Priapism associated with the switch from oral to injectable risperidone. J Clin Psychopharmacol 2006;26:626–628.
13Hendset, M, Molden, E, Refsum, H, Hermann, M. Impact of CYP2D6 genotype on steady‐state serum concentration of risperidone and 9 hydroxyrisperidone in patients using long‐acting injectable risperidone. J Clin Psychopharmacol 2009;29:537–541.
14de Leon, J, Susce, MT, Pan, RM et al. The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuations. J Clin Psychiatry 2005;66:15–27.
15Smith, EM, Iftikar, FI, Higgins, S et al. In vitro inhibition of cytochrome P450‐mediated reactions by gemfibrozil, erythromycin, ciprofloxacin and fluoxetine in fish liver microsomes. Aquat Toxicol 2012;109:259–266.
16Desta, Z, Kerbusch, T, Flockhart, DA. Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6). Clin Pharmacol Ther 1999;65:10–20.
17Bruce, MA, Hall, SD, Haehner‐Daniels, BD et al. In vivo effect of clarithromycin on multiple cytochrome P450s. Drug Metab Dispos 2001;29:1023–1028.
18Hersh, EV, Moore, PA. Drug interactions in dentistry: the importance of knowing your CYPs. J Am Dent Assoc 2004;135:298–311.
19Ishak, KJ, Tan, Y, Glass, J et al. Risk of discontinuation of risperidone after exposure to potentially interacting drugs: a nested case‐control study in patients with schizophrenia. Clin Ther 2008;30:1.